Products for Research Use Only
RegisterLogin

Volasertib

CAT: 0013-GTR19171822-02Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19171822-02Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Volasertib (BI 6727) is a highly potent and selective PLK1 inhibitor (IC50: 0.87 nM) with additional activity against PLK2 and PLK3. It promotes mitotic arrest and apoptosis in cancer cells and has demonstrated antitumor efficacy in various preclinical in vitro and in vivo models, supporting its investigation in oncology research.
CAS Number
755038-65-4
Product Name Alternative
BI 6727
Field of Research
Cell Biology
Purity
>98%
Bioactivity
Potent and selective inhibitor of Polo-like Kinase 1
Form
Powder
Solubility
Soluble in DMSO (up to at least 25 mg/ml)
Smiles
CC[C@H]1N (C (C) C) c2nc (Nc3ccc (cc3OC) C (=O) N[C@H]3CC[C@@H] (CC3) N3CCN (CC4CC4) CC3) ncc2N (C) C1=O
Molecular Formula
C34H50N8O3
Molecular Weight
618.82
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N-[4-[4- (Cyclopropylmethyl) piperazin-1-yl]cyclohexyl]-4-[[ (7R) -7-ethyl-5-methyl-6-oxo-8-propan-2-yl-7H-pteridin-2-yl]amino]-3-methoxybenzamide

Chemical Information

Volasertib

Volasertib is a member of the class of pteridines that is (7R)-7-ethyl-5-methyl-8-(propan-2-yl)-7,8-dihydropteridin-6(5H)-one substituted by a [4-({trans-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}carbamoyl)-2-methoxyphenyl]amino group at position 2. It is as polo-like kinase 1 inhibitor (IC50 = 0.87 nM) with potential antineoplastic activity. It has a role as an EC 2.7.11.21 (polo kinase) inhibitor, an antineoplastic agent and an apoptosis inducer. It is a secondary carboxamide, a member of benzamides, a monomethoxybenzene, a member of piperazines, a member of pteridines, a substituted aniline, a secondary amino compound, a tertiary amino compound and a member of cyclopropanes.

CAS Number755038-65-4
PubChem CID10461508
IUPAC NameN-[4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(7R)-7-ethyl-5-methyl-6-oxo-8-propan-2-yl-7H-pteridin-2-yl]amino]-3-methoxybenzamide
Molecular FormulaC34H50N8O3
Molecular Weight618.8
XLogP4.6
Topological Polar Surface Area106
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count10
Heavy Atom Count45
Formal Charge0
Complexity996
SMILES
CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C
InChI
InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1
InChIKey
SXNJFOWDRLKDSF-XKHVUIRMSA-N
Chemical Structure
2D Structure
2D structure of Volasertib
CAS: 755038-65-4
CID: 10461508
Formula: C34H50N8O3
MW: 618.8
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight618.8
XLogP34.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count10
Exact Mass618.40058749
Monoisotopic Mass618.40058749
Topological Polar Surface Area106 Ų
Heavy Atom Count45
Formal Charge0
Complexity996
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
468753-01Volasertib
HY-12137R-01Volasertib (Standard)
HY-12137A-01Volasertib (trihydrochloride)
TRC-V575182-25MGVolasertib-D3
A8558-5.1BI6727 (Volasertib)

Popular Products